Since MIF has been directly implicated in the regulation of endothelial differentiation [84], we believe that MIF as a tumor promoter proves again that monocytes-derived ECs can be a subpopulation of M2-TAMs, reaching the tumor to favor angiogenesis by also making part of the blood vessel structures. Here, MIF is linked to neoplasm.